Xencor Inc Asset Turnover Ratio (XNCR), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Xencor Inc  (NASDAQ: XNCR)
 

Xencor Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Xencor Inc asset turnover ratio, the ability of Xencor Inc's assets to generate revenue in the second quarter 2026, increased sequentially to 0.13 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as XNCR's position remain challenging.

Within sector 149 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 3152, from total ranking in the first quarter 2026 at 3701.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XNCR Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -17.56 % -18.55 % 32.88 % 29.11 % 25.71 %
Y / Y Revenue Change 17.46 % -86.2 % -46.51 % 18 % 82.41 %
Asset Turnover Ratio (TTM) 0.13 0.12 0.14 0.18 0.19
XNCR's Total Ranking # 3152 # 3701 # 3067 # 3137 # 3256
Seq. Asset Change -1.61 % -15.84 % 0.77 % -1.21 % -2.79 %
Seq. Revenue Change 1034.21 % -84.01 % 34.47 % -51.85 % 33.23 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 150
Healthcare Sector # 459
Overall Market # 3152

Asset Turnover Ratio Statistics
High Average Low
0.42 0.19 0.07
(Mar 31 2022)   (Jun 30 2015)




XNCR Company Profile • Back to XNCR Efficiency Comparisons • Compare XNCR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Immunocore Holdings Plc  0.40 $ 430.775  Millions$ 1,090.322  Millions
Quanterix Corporation  0.39 $ 152.716  Millions$ 387.301  Millions
Becton Dickinson And Company  0.39 $ 20,840.000  Millions$ 53,053.250  Millions
Schrodinger Inc   0.39 $ 259.035  Millions$ 663.600  Millions
Bausch and Lomb Corp  0.38 $ 5,324.000  Millions$ 13,873.250  Millions
Biomarin Pharmaceutical Inc  0.38 $ 3,406.614  Millions$ 8,880.837  Millions
Aligos Therapeutics Inc   0.38 $ 31.518  Millions$ 82.296  Millions
Veracyte Inc   0.38 $ 544.735  Millions$ 1,424.143  Millions
Protagonist Therapeutics inc   0.38 $ 281.992  Millions$ 738.220  Millions
Beta Bionics Inc   0.38 $ 119.513  Millions$ 313.898  Millions
Novavax inc   0.38 $ 413.796  Millions$ 1,088.785  Millions
Ars Pharmaceuticals Inc   0.38 $ 116.927  Millions$ 309.380  Millions
Arrowhead Pharmaceuticals Inc   0.37 $ 669.495  Millions$ 1,787.717  Millions
Sotera Health Company  0.37 $ 1,215.925  Millions$ 3,248.010  Millions
Elanco Animal Health Incorporated  0.37 $ 5,020.000  Millions$ 13,423.000  Millions
Intelligent Bio Solutions Inc   0.37 $ 4.215  Millions$ 11.273  Millions
Zimmer Biomet Holdings Inc   0.37 $ 8,508.800  Millions$ 23,024.775  Millions
Gossamer Bio Inc   0.36 $ 53.286  Millions$ 146.709  Millions
Aquestive Therapeutics Inc   0.36 $ 54.087  Millions$ 149.303  Millions
Ionis Pharmaceuticals Inc   0.36 $ 1,169.419  Millions$ 3,238.360  Millions
Bionexus Gene Lab Corp   0.36 $ 3.127  Millions$ 8.660  Millions
Sensus Healthcare Inc   0.36 $ 18.294  Millions$ 51.035  Millions
Innovative Eyewear Inc   0.36 $ 3.412  Millions$ 9.567  Millions
Iovance Biotherapeutics inc   0.36 $ 324.969  Millions$ 914.829  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,105.000  Millions$ 40,125.250  Millions
Cardiff Lexington Corporation  0.35 $ 10.213  Millions$ 29.417  Millions
The Cooper Companies Inc   0.34 $ 4,236.600  Millions$ 12,486.325  Millions
Invo Fertility Inc   0.34 $ 7.531  Millions$ 22.386  Millions
Pelthos Therapeutics Inc   0.32 $ 43.304  Millions$ 134.891  Millions
Volitionrx Limited  0.32 $ 2.458  Millions$ 7.672  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.